Package leaflet: Information for the user. AZOPT 10 mg/ml eye drops, suspension Brinzolamide

Similar documents
Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

Package Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac

Package leaflet: Information for the user. Optilamid 10 mg/ml, oogdruppels, suspensie Brinzolamide

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone

Package leaflet: Information for the patient. Brinzolamide 10 mg/ml Eye Drops, Suspension brinzolamide

IOPIDINE 5mg/ml Eye Drops, solution contain apraclonidine (as hydrochloride) as the active substance.

Package leaflet: Information for the user. SIMBRINZA 10 mg/ml + 2 mg/ml eye drops, suspension Brinzolamide/brimonidine tartrate

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

Dorzolamide 20 mg/ml Eye Drops, Solution

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

Package leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate

BrinzoQuin Eye Drops 1.0%

Package Leaflet : Information for the User. IOPIDINE 1%w/v eye drops solution (Apraclonidine Hydrochloride)

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

Package leaflet: Information for the user. GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution Bimatoprost/timolol

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP

Package leaflet: Information for the user. Carmellose sodium

Package leaflet: Information for the user. GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution, in single-dose container Bimatoprost/timolol

Package leaflet: Information for the user. Catacrom 2 % w/v Eye Drops, Solution. Sodium cromoglicate

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

Package leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin

1. What Octostim Nasal Spray is and what it is used for

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops

2 What you need to know before you use Beconase. Package Leaflet: Information for the user

Package leaflet: Information for the patient

LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml)

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate

ALPHAGAN EYE DROPS BRIMONIDINE TARTRATE

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

PACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)

Package leaflet: Information for the user. DuoTrav 40 micrograms/ml + 5 mg/ml eye drops, solution travoprost/timolol

1 What Flixonase is and what it is used for

Package leaflet: Information for the user. Sebivo 600 mg film-coated tablets Telbivudine

Package leaflet: Information for the user. Xalatan 50 micrograms/ml Eye drops, solution Latanoprost

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

PATIENT INFORMATION LEAFLET

2 What you need to know before you use Zofran Suppositories

Package leaflet: Information for the patient

PATIENT INFORMATION LEAFLET

Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe

Package leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide

Package leaflet: Information for the user. Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Budesonide Teva 0.5 mg/2 ml Nebuliser Suspension Budesonide

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Package leaflet: Information for the user

1. What Faslodex is and what it is used for

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

Package leaflet: Information for the patient. Forxiga 5 mg film-coated tablets Forxiga 10 mg film-coated tablets dapagliflozin

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

NEVANAC TM 0.1% Eye Drops

Proctosedyl Ointment Hydrocortisone/Cinchocaine hydrochloride/framycetin sulphate/aesculin

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

Package leaflet: Information for the user. Latanoprost Pfizer 50 micrograms/ml Eye drops, solution Latanoprost

Package leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin

ZADITEN Eye Drops 1.0%

Package Leaflet: Information for the User

2. What you need to know before you take DDAVP/Desmopressin Tablets

Package leaflet: Information for the user. Portrazza 800 mg concentrate for solution for infusion necitumumab

PACKAGE LEAFLET: INFORMATION FOR THE USER. Bydureon 2 mg powder and solvent for prolonged-release suspension for injection in pre-filled pen exenatide

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Beclometasone dipropionate

PACKAGE LEAFLET: INFORMATION FOR THE USER Rhinocort Aqua, 64 micrograms, Nasal Spray Budesonide

1. What Miacalcic is and what it is used for

Package leaflet: Information for the patient

Package leaflet: Information for the user. Raxone 150 mg film-coated tablets idebenone

Package leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride

Package leaflet: Information for the patient. Flynise 5 mg Orodispersible Tablets desloratadine

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Some general information on hepatitis A infection is given at the end of this leaflet.

Package leaflet: Information for the patient

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Otrivin Menthol (without preservative) 1 mg/ml nasal spray, solution Xylometazoline hydrochloride

Package leaflet: Information for the user

PATIENT INFORMATION LEAFLET

Benylin Children's Coughs & Colds 5mg/0.625mg per 5ml Syrup dextromethorphan, triprolidine

TIMALEN 0.5% eye drops

Package leaflet: Information for the user. Irprestan 150 mg film-coated tablets. Irprestan 300 mg film-coated tablets irbesartan

Package leaflet: Information for the patient. Selincro 18 mg film-coated tablets nalmefene

Transcription:

Package leaflet: Information for the user AZOPT 10 mg/ml eye drops, suspension Brinzolamide Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or your pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What AZOPT is and what it is used for 2. What you need to know before you use AZOPT 3. How to use AZOPT 4. Possible side effects 5. How to Store AZOPT 6. Contents of the pack and other information 1. What AZOPT is and what it is used for AZOPT contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors. It reduces pressure within the eye. AZOPT eye drops are used to treat high pressure in the eye. This pressure can lead to an illness called glaucoma. If the pressure in the eye is too high, it can damage your sight. 2. What you need to know before you use AZOPT Do not use AZOPT - if you have severe kidney problems. - if you are allergic to any of the ingredients of AZOPT. For a full list of ingredients please see section 6. - if you are allergic to medicines called sulphonamides. Examples include medicines used to treat diabetes and infections and also diuretics (water tablets). AZOPT may cause the same allergy. - if you have too much acidity in your blood (a condition called hyperchloraemic acidosis). If you have further questions, ask your doctor for advice. Warnings and precautions Talk to your doctor or pharmacist before using AZOPT: - if you have kidney or liver problems. - if you have dry eyes or cornea problems. 1

- if you are taking other sulphonamide medicines - if you have a specific form of glaucoma in which the pressure inside the eye rises due to deposits that block fluid draining out (pseudoexfoliative glaucoma or pigmentary glaucoma) or a specific form of glaucoma in which the pressure inside the eye (sometimes rapidly) rises because the eye bulges forward and blocks fluid draining out (narrow-angle glaucoma) Children and adolescents AZOPT is not to be used by infants, children or adolescents under 18 years of age unless advised by your doctor. Other medicines and AZOPT Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. If you are taking another carbonic anhydrase inhibitor (acetazolamide or dorzolamide, see section 1 What AZOPT is and what it is used for), talk to your doctor. Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. Women who may become pregnant are advised to use effective contraception during AZOPT treatment. The use of AZOPT is not recommended during pregnancy or breast-feeding. Do not use AZOPT unless clearly indicated by your doctor. Ask your doctor or pharmacist for advice before taking any medicine. Driving and using machines Do not drive or use machines until your vision is clear. You may find that your vision is blurred for a time just after using AZOPT. AZOPT may impair the ability to perform tasks requiring mental alertness and/or physical coordination. If affected, take care when driving or using machines. AZOPT contains benzalkonium chloride AZOPT contains a preservative (benzalkonium chloride) which may cause eye irritation and is known to discolour soft contact lenses. Contact with soft contact lenses should be avoided. If you wear contact lenses you should remove them prior to the application of AZOPT and wait at least 15 minutes after instillation of the dose before putting your lenses back in. 3. How to use AZOPT Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Only use AZOPT for your eyes. Do not swallow or inject. 2

The recommended dose is 1 drop in the affected eye or eyes twice a day - morning and night. Use this much unless your doctor told you to do something different. Only use AZOPT in both eyes if your doctor told you to. Take it for as long as your doctor told you to. How to use 1 2 3 Get the AZOPT bottle and a mirror Wash your hands Shake the bottle and twist off the cap. After the cap is removed, if the tamper evident snap collar is loose, remove before using product. Hold the bottle, pointing down, between your thumb and middle finger Tilt your head back. Pull down your eyelid with a clean finger, until there is a pocket between the eyelid and your eye. The drop will go in here (picture 1) Bring the bottle tip close to the eye. Use the mirror if it helps Do not touch your eye or eyelid, surrounding areas or other surfaces with the dropper. It could infect the drops Gently press on the base of the bottle to release one drop of AZOPT at a time. Do not squeeze the bottle: it is designed so that a gentle press on the bottom is all that it needs (picture 2) After using AZOPT, press a finger to the corner of your eye, by the nose (picture 3) for at least 1 minute. This helps to stop AZOPT getting into the rest of the body. If you take drops in both eyes, repeat the steps for your other eye. Put the bottle cap back on firmly immediately after use Use up one bottle before opening the next bottle. If a drop misses your eye, try again. If you are using other eye drops, leave at least 5 minutes between putting in AZOPT and the other drops. Eye ointments should be administered last. If you use more AZOPT than you should If you get too much in your eyes, rinse it all out with warm water. Do not put in any more drops until it s time for your next regular dose. If you forget to use AZOPT Use a single drop as soon as you remember, and then go back to your regular routine. Do not use a double dose to make up for a forgotten dose. If you stop using AZOPT If you stop using AZOPT without speaking to your doctor, the pressure in your eye will not be controlled which could lead to loss of sight. 3

4. Possible side effects Like all medicines, this medicine can cause side effects, although not everyone gets them. The following side effects have been seen with AZOPT. Common side effects (may affect up to 1 in 10 people)) - Effects in the eye: blurred vision, eye irritation, eye pain, eye discharge, itchy eye, dry eye, abnormal eye sensation, redness of the eye. - General side effects: bad taste. Uncommon side effects (may affect up to 1 in 100 people) - Effects in the eye: sensitivity to light, inflammation or infection of the conjunctiva, eye swelling, eyelid itching, redness or swelling, deposits in eye, glare, burning sensation, growth on surface of eye, increased pigmentation of the eye, tired eyes, eyelid crusting, or increased tear production. - General side effects: decreased or reduced heart function, a forceful heartbeat that may be rapid or irregular, decreased heart rate, difficulty breathing, shortness of breath, cough, decreased red blood cell count in blood, increased chlorine level in blood, dizziness, difficulty with memory, depression, nervousness, decreased emotional interest, nightmare, generalized weakness, fatigue, feeling abnormal, pain, movement problems, decreased sex drive, male sexual difficulty, cold symptoms, chest congestion, sinus infection, throat irritation, throat pain, abnormal or decreased sensation in mouth, inflammation of the lining of the oesophagus, abdominal pain, nausea, vomiting, upset stomach, frequent bowel movements, diarrhoea, intestinal gas, digestive disorder, kidney pain, muscle pain, muscle spasms, back pain, nose bleeds,, runny nose, stuffy nose, sneezing, rash, abnormal skin sensation, itching, smooth skin rash or redness covered by elevated bumps, skin tightness, headache, dry mouth, debris in eye. Rare side effects (may affect up to 1 in 1,000 people) - Effects in the eye: corneal swelling, double or reduced vision, abnormal vision, flashes of light in the field of vision, decreased eye sensation, swelling around the eye, increased pressure in eye, damage to the optic nerve. - General side effects: memory impairment, drowsiness, chest pain, upper respiratory tract congestion, sinus congestion, nasal congestion, dry nose, ringing in ears, hair loss, generalized itching, feeling jittery, irritability, irregular heart rate, body weakness, difficulty sleeping, wheezing, itchy skin rash. Not known (frequency cannot be estimated from the available data): - Effects in the eye: eyelid abnormality, visual disturbance, corneal disorder, eye allergy, decreased growth or number of eyelashes, eyelid redness. - General side effects: increased allergic symptoms, decreased sensation, tremor, loss or decrease in taste, decreased blood pressure, increased blood pressure, increased heart rate, joint pain, asthma, 4

pain in extremity, skin redness, inflammation, or itching, abnormal liver blood tests, swelling of the extremities, frequent urination, decreased appetite, feeling unwell. Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system (see details below). By reporting side effects you can help provide more information on the safety of this medicine. United Kingdom Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard Ireland HPRA Pharmacovigilance Earlsfort Terrace IRL - Dublin 2 Tel: +353 1 6764971 Fax: +353 1 6762517 Website: www.hpra.ie e-mail: medsafety@hpra.ie Malta ADR Reporting Website: www.medicinesauthority.gov.mt/adrportal 5. How to store AZOPT Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the bottle and box after EXP. The expiry date refers to the last day of the month. This medicine does not require any special storage conditions. You must throw away a bottle four weeks after you first opened it, to prevent infections. Write down the date you opened each bottle in the space below and in the space on the bottle label and box. For a pack containing a single bottle, write only one date. Opened (1): Opened (2): Opened (3): Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6 Contents of the pack and other information What AZOPT contains - The active substance is brinzolamide. Each milliliter contains 10 mg of brinzolamide. 5

- The other ingredients are benzalkonium chloride, carbomer 974P, edetate disodium, mannitol (E421), purified water, sodium chloride, tyloxapol. Tiny amounts of hydrochloric acid or sodium hydroxide are added to keep acidity levels (ph levels) normal. What AZOPT looks like and contents of the pack AZOPT is a milky liquid (a suspension) supplied in a pack containing a 5 ml or a 10 ml plastic (droptainer) bottle with a screw cap, or in a pack containing three 5 ml plastic (droptainer) bottles with screw caps. Not all pack sizes may be marketed. Marketing Authorisation Holder Novartis Europharm Limited Frimley Business Park Camberley GU16 7SR United Kingdom. Manufacturer S.A. Alcon-Couvreur N.V Rijksweg 14 B-2870 Puurs Belgium For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder. Ireland United Kingdom Novartis Ireland Limited Novartis Pharmaceuticals UK Ltd. Tel: +353 1 260 12 55 Tel: +44 1276 698370 Malta Novartis Pharma Services Inc. Tel: +356 2122 2872 This leaflet was last revised in 05/2017 Detailed information on this product is available on the website of the European Medicines Agency (EMA) http://www.ema.europa.eu 6